Open access peer-reviewed chapter

Regulation of the Immune Response in Cysticercosis: Lessons from an Old Acquainted Infection

Written By

Jonadab E. Olguín and Luis Ignacio Terrazas

Submitted: 12 May 2021 Reviewed: 26 August 2021 Published: 04 November 2021

DOI: 10.5772/intechopen.100137

From the Edited Volume

Current State of the Art in Cysticercosis and Neurocysticercosis

Edited by Jorge Morales-Montor, Abraham Landa and Luis Ignacio Terrazas

Chapter metrics overview

380 Chapter Downloads

View Full Metrics

Abstract

In the last decades, we have learned some critical lessons about the relationship between the human body and its interaction with many infectious diseases, where regularly, the immune system has a major role in protection. We learned to differentiate between the immune response occurring in either an intracellular or extracellular parasitic infection, between innate and adaptive immune response, between either inflammatory or anti-inflammatory responses, and finally, we learned to recognize very particular mechanisms, such as the inability of the immune system to respond during very particular scenarios, such as the inability of T cells to both proliferate and produce cytokines even after their exposure to mitogens or specific-antigens. Along with our increase in the knowledge in immunology, we figured out that immunoregulation and immunosuppression are processes used by many parasites to reduce the capacity of the immune system to eliminate them, and to persist in the host favoring their transmission and also to complete their life cycles. Immunoregulation involves several mechanisms such as anergy, apoptosis, induction of both suppressive cytokines and membrane-bound molecules, as well as specialized cell populations of the immune system like regulatory T cells, Alternative Activated Macrophages, or Myeloid-derived Suppressor Cells, that together modify the outcome of the immune response. In this chapter we will review the general differences between the different types of immunoregulation, the kind of cellular populations of the immune system used by the helminths Taenia solium and Taenia crassiceps to induce immunoregulation and immunosuppression and also, the mechanisms used by these parasites such as mimicking molecules of the immune system to replace directly these mechanisms. Understanding and deciphering all these regulatory mechanisms could be useful to develop new tools to control this infection.

Keywords

  • Cysticercosis
  • Immunoregulation
  • Immunosuppression
  • Taenia solium
  • Taenia crassiceps
  • Regulatory T cells (Treg cells)
  • Alternative Activated Macrophages (AAM)
  • Myeloid-derived Suppressor Cells (MDSC)

1. Introduction

Taeniasis and cysticercosis, both neglected diseases, are two kinds of infections caused by the same parasite, Taenia solium. Taeniasis is the intestinal infection caused by the adult form of the tapeworm T. solium, while cysticercosis is the tissue infection caused by the larval stage, cyst or cysticercus of T. solium [1]. Whereas taeniasis only affects the human and it is restricted to the small intestine, cysticercosis affect two hosts, the human and the swine, besides this stage of the parasite can allocate at different anatomical sites including the brain, causing neurocysticercosis (NCC). The vast majority of medical findings by natural infection has been made during cysticercosis, given its clinical relevance when the parasite encroaches on the central nervous system including the brain and the eye [2]. In the past, NCC represented a major health problem mainly in developing countries [3], being highly prevalent in the general registration of autopsies [3]. The only way to find samples for the study of NCC, were in patients diagnosed by neuroimaging: magnetic resonance and computed tomography, and also by determination of specific antigens by ELISA and western blot from blood and cerebrospinal fluid samples [4, 5].

Because taeniasis remains asymptomatic, there are no symptoms directly associated with the disease, only general symptoms like abdominal bloating and abdominal pain [1, 5]. For this reason, a model to understand the immunological interactions between the host and the parasite and also, to understand the evolutionary capacity of Taenia to survive in the host was necessary. Animal models like hamsters, gerbils and chinchillas, were developed in the past to have a better understanding of the immunology in this field [6], but a limited information about it was published, having a focus in the inflammatory response in the intestinal mucosa of chinchillas receiving an immunosuppressant treatment with methyl-prednisolone [7]. Because of the nature to develop taeniasis and the necessity to have a better understanding of the immune response against T. solium, it was necessary to know the immunology and the mechanism of protection used by a “close familiar” to this parasite: Taenia crassiceps.

Advertisement

2. General aspects of the immune response during NCC and Taeniasis

T. crassiceps is a tapeworm that generates natural infections in some definitive canine hosts like dogs, red foxes, and wolves in the northern hemisphere of the world. It also has an extensive reproduction rate in the pleural and peritoneal cavities of their intermediate host like wild rodents [8]. For a better understanding of their life cycle, go to the reference [8]. T. crassiceps ORF strain was obtained by Dr. Reino Freeman in 1952. This strain has a deficient capacity to develop the scolex, therefore, cannot colonize the intestines of its definitive hosts [9]. Most of the research about the immunology of T. crassiceps has been developed with the ORF strain, injecting either 10 or 20 metacestodes of this parasite in the peritoneal cavity of syngenic female BALB/c mice [10, 11].

The immune response against T. crassiceps has been investigated in an extensive way. During the acute infection by this helminth a strong Th1 immune response characterized by high levels of IL-2 and IFN-γ is induced and has been associated with host protection, but as the infection becomes chronic, levels of both IL-2 and IFN-γ decrease as well as IL-12 produced by macrophages [12]. These reduced levels of Th1-type cytokines correlate with increased levels of IL-4 at chronic infection stages, suggesting a switch between inflammatory response in the acute infection to an anti-inflammatory response in chronic infection, favoring the adequate microenvironment for both, parasite development and their persistence in the host (Figure 1). Susceptibility to T. crassiceps infection is STAT6-mediated, characterized by strong IgG1, IgE, IL-4 and IL-13 production [13]. Therefore, unlike the case of the vast majority of helminth parasitic infections, protection during experimental cysticercosis is mediated by Th1-type immune responses, while parasite establishment is associated with Th2-type mediated immune responses [14]. One of the most relevant findings observed during experimental cysticercosis, was the reduced proliferative capacity of T lymphocytes obtained from infected mice to either nonspecific or specific antigens during chronic infection, suggesting the strong immunosuppressive capacity of T. crassiceps [12, 15].

Figure 1.

Hypothetical/integrative model of immune regulation triggered by T. solium and T. crassiceps infection and their released products on different types of cells. Products of both parasites can be recognized by innate cells through several pattern recognition receptors, including TLRs, CD205, among others, and induce tolerogenic DCs or modulate the activation of macrophages by inducing the expression of different inhibitory molecules in its membrane such as PDL1, PDL2, Galectin-9 (Gal-9) as well as soluble inhibitory factors such as PGE2, and IL-13, while favors the expression of genes associated with M2 polarization, such as arginase, FIZZ1 and YM1, leading to the inhibition of T cell proliferation. In contrast, the inflammatory properties of both DCs and macrophages are inhibited by these parasite molecules and the production of TNF-α, IL-12, iNOS and ROS are dramatically reduced. Additionally, TsES and TcES inhibit T cell responses through the induction of T regulatory cells as well as B regulatory cells which both are an important source of IL-10. These infections together with their secreted products can also induce a Th2-biased response and a reduced CD8 response.

On the other hand, evidence from subcutaneous, visceral, muscle, lung and cardiac tissue infected with T. solium in patients suggest that, out of the nervous central system (NCS), this infection causes no symptoms, reducing the possibility to understand and describe the occurring steps during early immune responses [1, 16]. Once inside of NCS, T. solium induces different levels of damage depending on the developing site. If the cysticercus is located in the brain parenchyma, it survives during different periods of time, from months to years, but eventually evolves in resolution [1, 2]. However, if the infection is located outside of the parenchyma’s (subarachnoid) brain, it is associated with edema, inflammation and increased mortality rates around 20% in patients without a correct treatment [2, 17]. Besides its location on the NCS, also exists a relationship between the intensity of the symptomatology and the number and size of the larvae causing the infection. In fact, it was recently hypothesized that the gut-brain-axis has a major role in the manifestation of symptoms during NCC, mainly in patients with mental illness, depression and epilepsy [18], highlighting the importance for the microbiota in this field. Also, it was suggested that these interactions for the gut-brain-axis are dependent on galectin-7 (Gal-7) expression in brain endothelial cells during human T. solium cysticercosis [19]. Thus, the main actors for the development of cysticercosis are the host immune response, the microenvironment for the parasite development either the gut or NCS, the microbiota, and the host health status.

The immune response described in the T. solium rodent model has been helpful and relevant to understand the immunobiology during taeniasis and cysticercosis, being a main feature the suppression of the immune response. Next, we will try to describe both the immunoregulatory mechanisms and the direct effects of molecules secreted by Taenia parasites to induce immunoregulation.

Advertisement

3. Immunoregulation during cysticercosis

An inflammatory response during the initial infection process is necessary to induce immunity, to reduce parasite load and finally to have protection in cysticercosis. However, since basic science started to clarify the role of the immune response during cysticercosis, some special discoveries have been observed only in this helminth infection, suggesting a process of transformation from inflammation to an anti-inflammatory response, tipping the balance towards the parasite survival. Is necessary to pay attention in the fact that, during some helminth infections, the Th1 to Th2 switch is caused to keep the balance between immunity in the host with tissue repairing, and for the survival of the parasite o for its expulsion from the host, example of that are Schistosoma mansoni, Nippostrongylus brasiliensis and Heligmosomoides polygyrus infections [20, 21]. However, this Th1 to Th2 switching in cysticercosis appears to absolutely favor parasite survival. Also, this switch process is an initial step to induce an immunosuppressive process orchestrated by the parasite, or also, as a possibility, the microenvironment caused by the infection has a strong effect culminating in the incapacity to the immune response to react against the infection (Figure 1). Some evidence suggests that immunosuppression may be caused by T-cells, myeloid-derived cells or directly by parasite molecules like Taenia crassiceps excreted/secreted antigens (TcES) or Taenia solium excreted/secreted antigens (TsES). Also, it was suggested that asymptomatic NCC is caused by a strong period of immunosuppression by live T. solium parasites, because brain inflammation is not observed during the development of the infection and while the parasite remains alive [22].

3.1 Immunoregulation mediated by T-cells

During some intracellular parasitic infections, like toxoplasmosis, trypanosomiasis and leishmaniasis, an incapacity of T lymphocytes to proliferate in response to antigen-specific or polyclonal mitogens has been described, mainly during acute infection [23, 24, 25, 26]. Although the general observation is that the process of immunosuppression starts at the beginning of the chronic T. crassiceps infection, it was shown that during acute intraperitoneal (ip) infection in mice, there is a significant decreased percentage of T-CD4+, T-CD8+ cells and B-CD19+ cells at the infection site, starting at 3 days post infection (dpi) and culminating at 16 dpi [27]. These results correlate with increased levels of apoptosis, mainly in eosinophils. Perhaps, T. crassiceps begins to develop its suppressive microenvironment since the beginning of the development of the infection, such as reported for protozoan infections. During T. crassiceps chronic infection, a reduced proliferative capacity of T cells was described [12], especially in CD8-cytotoxic T cells [28]. Recent observations by our laboratory described that, this reduced capacity to induce cytotoxicity by CD8+ cells is caused by increased expression of Tim-3 and PD1 molecules in an IL4-Rα, STAT-1 and IFN-γ independent-pathway (Figure 1, Olguin JE et al., unpublished data). Interestingly, both expression of Tim-3 and PD1 is increased in adaptive regulatory CD4+Foxp3 T cells but not in natural Treg cells. In fact, during the chronic phase of experimental cysticercosis, we observed reduced percentages of Treg cells, which is contrasting with some published data. For example, a study reports that cocultured cysticerci of T. solium with human monocyte-derived DCs, induces Foxp3 expression in CD4+ naïve T cells in vitro and also, increased percentage of suppressive-related molecules (Figure 1) [29]. The same research group showed a descriptive study in patients with NCC, observing an increased expression of natural and adaptive Treg cells in blood [30], but the authors did not show, whether these induced and natural Treg cells had the capacity to suppress another population of immune cells, for example either T-CD8 or activated CD4 T cells. Maybe, the differences observed between NCC and experimental cysticercosis in Treg cells are explained by the site where the sample was obtained (NCS and blood in T. solium, peritoneum in T. crassiceps), and by the nature of the infection. However, it is clear that, whatever scenario is observed, T cell-mediated regulation is a critical mechanism involved during the development of experimental or natural cysticercosis. Also, observations made by our group in T. crassiceps infection are different to those done in other helminth infections. A recent study of hookworms like Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides and others, showed by mass cytometry a clear profile of Th2 cells, favoring increased expression of CTLA-4 in Treg cells, and B cells producing IL-10 in infected Europeans and Indonesians patients [31]. Maybe, it is necessary to describe more specific surface markers to define the population of suppressive and/or regulatory T cells. For example, it has been described as a highly suppressive T regulatory Type 1 population (Tr1) during a helminth scenario by the co-expression of CD49 and LAG-3 [32]. Tr1 cells are different from natural regulatory (Treg) cells because they do not express constitutively the Foxp3 transcription factor [33].

As well as in T. crassiceps infection, during NCC a period of immunosuppression has been reported. One study extracting polymorphonuclear (PMN) cells from 11 patients diagnosed with NCC, showed a clear immunosuppression in response to TsES antigens from the scolex of T. solium, also NCC patients with calcified cysts displayed increased immunosuppression [34]. The same study showed the suppressor capacity of TsES, completely inhibiting the proliferative response to mitogens like phytohaemagglutinin (PHA) and concanavalin A (ConA) [34]. These results are different to those published by a different research group, under the same conditions, where NCC patients without treatment did not show differences in the percentages of CD3+, CD4+ and CD8+ T cell populations. Moreover, blood cells from these NCC patients showed the same proliferative capacity to ConA or crude T. solium antigens compared with controls, and finally also PMN cells produced IL-2 [4]. Is not clear what is the correct scenario, maybe another process or data were not considered in the clinical history between these both studies, like age of the patient, sex, or any oncological or immunosuppressive constitutive status. In fact, more recently published data showed that if analyzed groups of patients with NCC are divided by the local site of the infection in either parenchymal (infection is resolved in general) or subarachnoid (increased symptomatology and pathology), the group of patients with subarachnoid infection has an increased immunoregulatory microenvironment characterized by IL-10, TGF-β and expanded Treg cell frequencies ex-vivo [35].

3.2 Immune-regulatory myeloid-derived mechanisms

The generation of an immune-regulatory environment could have an effect not exclusively in T cells, but in all immune cells, including all myeloid-derived lineages such as macrophages, dendritic cells (DCs) and PMNs. Thus, myeloid cells are key players in the immune response against cysticercosis. In fact, there is evidence suggesting an increased profile of alternative activated macrophages or M2 macrophages involved in parasite expulsion and tissue repair during helminth infections, which induce protection to the host [36]. However, in cysticercosis, the scenario appears to be different.

During T. crassiceps infection it was suggested that recruited CD11b+Gr1+ myeloid-derived suppressor cells (MDSCs) impaired the T cell proliferation by secretion of high amounts of nitric oxide (NO) at early stages of an intraperitoneal infection. This classic inflammatory activation is switched at chronic stages, where CD11b+Gr1+ cells express arginase, YM-1 and FIZZ1 genes, associated with an M2 phenotype (Figure 1). This immunosuppressive microenvironment favors IL-4 and IL-13 production, expanding the MDSCs population and also, inducing lipid mediators’ activation like 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatetraenoic acid, associated with the immunosuppression of T cell proliferation [37]. Also, alternative-activated macrophages (AAMs or M2) from chronic T. crassiceps infection have the ability to produce high levels of IL-6 and Prostaglandin E2 (see below), reducing the proliferative capacity of CD4+ T cells in a STAT-6 dependent-pathway (Figure 1) [11], suggesting that AAMs are necessaries to induce the permissive microenvironment for the colonization of T. crassiceps infection. In fact, it was demonstrated that an early in vivo depletion of AAMs by using clodronate liposomes, increases the resistance against T. crassiceps [38], making stronger the hypothesis that experimental cysticercosis has an AAMs-dependence for a successful infection. Later, it was shown that these AAMs induce anergy on CD4+ T cells during T. crassiceps infection, and that such an event depends on PDL1 and PDL2 expression in the surface membrane of AAMs [39].

On the other hand, monocyte-derived DCs co-cultured with CD4 naïve cells in presence of T. solium cysticerci promotes both, Treg and DCs cells differentiation towards a tolerogenic profile featured by a higher expression of Signaling Lymphocytic Activation Molecule 1 (SLAM1), B7-H1 and CD205 molecules (Figure 1). These results suggest that T. solium cysticerci has the ability to induce both Treg cells as well as suppressive or tolerogenic DCs [29].

Advertisement

4. Regulatory mechanisms mediated by cytokines, antibodies, and soluble immune factors

4.1 IL-10

IL-10 is produced by innate cells like myeloid and plasmacytoid DCs and macrophages, and is also produced by Breg cells, Th2, Th17 and Treg cells from the adaptive immune response. This capacity to be produced from several immune cell lineages, depends on the signal pathways activated like ERK, and also from transcription factors like STAT3, STAT4, STAT6 and cytokines like TGF-β [40]. One of the main features of IL-10 is its capacity to induce immunosuppression, reducing IL-12 and TNF-a levels. By transcriptomic array analyses, we observed that miR-125a-5p, miR-762, and miR-484 microRNAs, are associated with the targeting of inflammatory profiles of macrophages favoring the IL-10 signaling pathway, suggesting that T. crassiceps and its products induce post-transcriptional suppression mechanisms of the immune response [41]. Earlier studies performed in experimental cysticercosis caused by chronical T. crassiceps infection, indicated a strong Th2 biased immune response featured by high production of IL-4, IL-6 and IL-13 cytokines as well as increased IL-10 levels [12]. These findings were just recently confirmed by an independent group highlighting the importance of IL-10 cytokine [42].

4.2 Transforming growth factor beta (TGF-β)

TGF-β is a cytokine involved in some situations during immune and not immune phenomena. It has a role in the control of cell proliferation and differentiation of some cell types like either Treg or Th17 cells [43, 44]. Also, by itself, it has the capacity to induce a suppressive environment in scenarios where required, like mucosal immune reactions. Dysregulation of TGF-β generates inflammatory disorders such as spontaneous colitis [45]. In the T. solium genome were found some genes homologs with the TGF-β receptor family, including some evolved in its down-stream transduction pathway. In fact, it was confirmed by RT-PCR and western blot assays that cysts of T. solium express the type I and type II receptor for TGF- β. Also, the addition of TGF- β to the culture media for both T. crassiceps and T. solium adequate conditions, promotes both the reproduction of T. crassiceps and the survival of T. solium in vitro. Finally, high levels of TGF-β were found in the cerebrospinal fluid from patients diagnosed with NCC [46]. All these results suggest a strong direct and indirect role for TGF-β in the process of immunosuppression during T. solium infection.

4.3 Osteopontin

Osteopontin (OPN) is a Th1 type cytokine upstream of IL-12 that has a role in the granuloma formation in inflamed tissues [47]. It was shown that blood cells co-cultured with TsES or viable cysticerci from T. solium led to decreased levels of OPN, IL-12 and IFN-γ. Injection of recombinant OPN into tissues surrounding implanted cysticerci enhances inflammatory responses, which suggests that TsES may have molecules that block OPN activity as a target for immunosuppression [48].

4.4 Antibodies

Humoral immune response has been described for its essential role against helminth infections, being IgE antibody isotype a cornerstone to induce protection [49]. However, during taeniasis and cysticercosis, little information about the role of B cells has been described. It was shown that an antibody called anti-GK-1 (IgG) obtained from the serum of pigs infected with T. solium, has an epitope shared by both T. crassiceps and T. solium [50] and also, has the capacity to inhibit the development of T. solium cysticerci into adult stage by recognition of the cyst protein KE7 [51]. This protective role for anti-GK1 antibodies is complement-mediated during T. solium infection [50, 52]. However, these results are the only data obtained for humoral immune response during taeniasis and cysticercosis. During experimental cysticercosis and during NCC, is clear that immunosuppression favors the establishment of the parasite, and this GK-1 antibody-mediated mechanism has naturally no success; maybe a molecule of the parasite has the capacity to inhibit this protective function, which in turn induces immunosuppression. Is necessary to clarify this point with specific and deeper experiments.

4.5 Prostaglandin E2

Some lipids from eicosanoid family derivatives from arachidonic acid, like prostaglandin E2 (PGE2), have been described as potent immunosuppressant molecules [53]. It has been described that administration in vivo of PGE2 in T. crassiceps infected mice favors both parasite growth and cytokine production of IL-10 and IL-6 by splenocytes and reduces the proliferative capacity of splenocytes stimulated with ConA. On the other hand, the administration of indomethacin, an inhibitor of PGE2 synthesis, induced the reduction of both the parasite growth and cytokine production of IL-10 and IL-6, increasing the ConA-proliferative response of splenocytes (Figure 1) [54]. These results suggest that T. crassiceps can induce the production of PGE2 indirectly from some cellular types, like almost all cells of the host, as a mechanism of immunoregulation [54]. Also, it is possible that some molecules from TcES could be a similar biomolecule like PGE2, mimicking their function and directly inducing immunosuppression, like the TGF-β phenomenon observed during T. solium infection.

Advertisement

5. Immunoregulation mediated by Taenia-derived products

5.1 Paramyosin

Paramyosin is an α-helical coiled coil 100 KDa protein that is present in muscle and tegument of the larval stage of T. solium [55]. This protein can bind to the protein C1q of the complement, therefore, inhibiting the complement cascade [56]. This was the first evasive mechanism described for this parasite. Vaccine strategies performed to block the activity of this protein resulted in almost 80% of protection [57].

5.2 Glutathione transferase

Glutathione transferase (GST) is an essential enzyme in the metabolism of cestodes, mainly for the detoxification of xenobiotics, it is localized on the cysticerci tegument of T. solium [58]. This molecule appears to have a immunomodulatory role given that its use as a putative vaccine was able to reduce parasite load on experimental cysticercosis, mainly by activating macrophages to produce pro-inflammatory cytokines [59]. These data indicate that T. solium and T. crassiceps may have pro and anti-inflammatory mixed molecules.

5.3 TcES or TsES antigens

Analysis of T. solium excreted/secreted antigens (TsES) showed a cysteine protease activity for these molecules, having the capacity to induce apoptosis specifically in CD4+ but no in CD8+ T cells, which is evidence of a direct mode of immunosuppression over a population of the immune response (Figure 1). Cocultured cysts of T. solium with lymphocytes in vitro have not the same effect to induce apoptosis like TsES [60]. Also, it was suggested that natural infection of pigs with T. solium cysticerci recruits CD3+ cells to the brain which are killed by apoptosis [61].

Studies in our laboratory demonstrated that TcES products have the capacity to block TLR4 and TLR9 initial signaling pathway in DCs, which has a negative effect over their maturation, their production of pro-inflammatory cytokines and also, to induce alloreactive T cell proliferation, but in an IL-10 independent pathway. All these regulatory effects were carbohydrate-dependent in the TcES, because the chemical alteration of glycans switch this tolerogenic environment to one favoring DCs maturation and secretion of pro-inflammatory cytokines (Figure 1) such as IL-12 and TNF-α [62]. Moreover, it was shown that the in vivo treatment with TcES, has the capacity to induce the differentiation of monocytes to AAMs expressing PDL1 and PDL2, which in turn down-modulate the activity of experimental autoimmune encephalomyelitis EAE [63]. Furthermore, it was shown that in the murine model of NCC with the helminth Mesocestoides corti, the inhibition of TLR-initiated regulation of inflammatory cytokines exists. This effect is caused by an inhibition of acetylation and phosphorylation of both NF-kB and JNK which causes an accumulation of Ca2+ in the endoplasmic reticulum [22]. Probably, this phenomenon is similarly used by T. solium during initial establishment of the infection, however, deeper research is necessary in this field (Figure 1).

Also, it was shown that the nature of antigens of T. solium is essential to induce a proper immune response. Within T. solium crude lysate antigen, cyst wall antigen, and cyst fluid antigen, only low molecular weight fractions of cyst fluid are immunodominant, with the capacity to induce the production of inflammatory cytokines, but mainly higher levels of IL-10 and IL-4 by stimulated lymphocytes of patients with NCC [64]. Besides, it was suggested that the time of TcES obtention has a different impact over the kind of immunosuppression observed; TcES obtained early in infection, suppress the proliferative response of splenocytes stimulated with ConA than TcES obtained late in infection. Also, these early obtained TcES suppress the production of IFN-γ and IL-4 efficiently [65].

Advertisement

6. Conclusions

It has been largely known that helminthic infections induce strong Th2-mediated immune responses associated with regulation of inflammatory responses. Here, it has been described the different molecules and pathways altered by T. solium and T. crassiceps infection. Is noteworthy that some clinical studies point out that this immunomodulation favors both the parasite and host survival when the parasite is allocated in the brain, mainly because the inflammatory response is inhibited, avoiding the damage expected from a strong inflammatory response.

The anti-inflammatory activities and immunoregulatory properties found in both T. solium and T. crassiceps parasites and their products, can be useful beyond the host–parasite interactions. During some allergic diseases like asthma and rhinitis, the hygiene hypothesis has strengthened the idea of the historical necessity to down-modulate the immune response by mechanisms of natural coevolution, like the infection with helminth parasites [66]. In the same order of ideas, because of all these suppressive capacities of both T. crassiceps parasites and their TcES molecules, we hypothesized that it probably has the capacity to modulate chronic diseases associated with inflammation. We observed a clear role of both T. crassiceps and their TcES antigens in the modulation of experimental autoimmune encephalomyelitis (EAE) [67, 68], colitis-associated colon cancer (CAC) [69, 70], experimental colitis [71] and type 1 diabetes [72].

Lately, we have observed that the mechanisms used by the parasites that cause infectious diseases, such as taeniasis and cysticercosis, are very similar processes, and we dare to suggest that they are the same, to those occurring during the main oncological (solid) pathologies. The fact that a carcinogenic transformed cell induces an immunosuppressive process through immune-checkpoints such as PD1, CTLA-4 or Tim3, is a mechanism that had already been described in the past, during cysticercosis. So, immunoregulation and immunosuppression are natural selection mechanisms that pathogens take advantage of to be able to survive in a hostile environment and turn it to favor them, to face a variety of processes of continuous and varied attack of the immune response. Therefore, understanding and deciphering the why, how, and when these natural selection processes occur, we will be able to apply the lesson obtained during infectious diseases in processes affecting the current public health, like the main oncological pathologies.

Advertisement

Acknowledgments

“This work was supported by CONACYT grant number A1-S-37879 and DGAPA-PAPIIT-UNAM grants numbers IA209720 and IN226519.

Advertisement

Conflict of interest

“The authors declare no conflict of interest.”

Advertisement

AAMAlternatively activated macrophages
ConAConcanavalin A
CTLA-4Cytotoxic T-Lymphocyte Antigen 4
DCsDendritic cells
DPIDays post-infection
EAEExperimental autoimmune encephalomyelitis
ELISAEnzyme-linked Immuno Assay
ERKExtracellular signal regulated kinases
Foxp3Forkhead box P3 transcription factor
FIZZ1Found in inflammatory zone 1 gene
Gal-9Galectin-9
Gal-7Galectin-7
IFN-γInterferon-gamma
IgEImmunoglobulin E
IgGImmunoglobulin G
IL-2Interleukin-2
IL-4Interleukin-4
IL4RαInterleukin4 receptor α
IL-6Interleukin-6
IL-10Interleukin-10
IL-12Interleukin-12
IL-13Interleukin-13
IPIntraperitoneal
MDSCMyeloid-derived suppressor cells
NCCNeurocysticercosis
NCSNervous Central System
NONitric oxide
OPNOsteopontin
PD1Programmed death 1
PDL1Programmed Death-ligand 1
PDL2Programmed Death-ligand 2
PGE2Prostaglandin E2
PHAphytohaemagglutinin
PMNPolymorphonuclear cells
RT-PCRReal time polymerase chain reaction
SLAMF1Signaling Lymphocytic Activation Molecule 1
STAT3Signal transducer and activator of transcription 3
STAT4Signal transducer and activator of transcription 4
STAT6Signal transducer and activator of transcription 6
TcESTaenia crassiceps excreted/secreted antigens
TGF-βTumor growth factor beta
TNF-αTumor Necrosis Factor Alpha
Th1T helper cells 1
Th2T helper cells 2
Th17T helper cells 17
Tim3T-cell Immunoglobulin domain and Mucin domain 3
TLR4Toll-like receptor 4
TLR9Toll-like receptor 4
TregRegulatory T cells
Tr1T regulatory Type 1 population
TsESTaenia solium excreted/secreted antigens

References

  1. 1. Gonzales I, Rivera JT, Garcia HH, Cysticercosis Working Group in P. Pathogenesis of Taenia solium taeniasis and cysticercosis. Parasite immunology. 2016;38:136-146. DOI: 10.1111/pim.12307
  2. 2. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. The Lancet Neurology. 2014;13:1202-1215. DOI: 10.1016/S1474-4422(14)70094-8
  3. 3. Flisser A, Correa D. Neurocysticercosis may no longer be a public health problem in Mexico. PLoS neglected tropical diseases. 2010;4:e831. DOI: 10.1371/journal.pntd.0000831
  4. 4. Medina-Escutia E, Morales-Lopez Z, Proano JV, Vazquez J, Bermudez V, Navarrete VO, et al. Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression. The Journal of parasitology. 2001;87:587-590. DOI: 10.1645/0022-3395(2001)087[0587,CIRATT]2.0.CO;2
  5. 5. Ito A, Plancarte A, Ma L, Kong Y, Flisser A, Cho SY, et al. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. The American journal of tropical medicine and hygiene. 1998;59:291-294. DOI: 10.4269/ajtmh.1998.59.291
  6. 6. Avila G, Teran N, Aguilar-Vega L, Maravilla P, Mata-Miranda P, Flisser A. Laboratory animal models for human Taenia solium. Parasitology international. 2006;55 Suppl:S99-S103. DOI: 10.1016/j.parint.2005.11.015
  7. 7. Maravilla P, Garza-Rodriguez A, Gomez-Diaz B, Jimenez-Gonzalez DE, Toral-Bastida E, Martinez-Ocana J, et al. Chinchilla laniger can be used as an experimental model for Taenia solium taeniasis. Parasitology international. 2011;60:364-370. DOI: 10.1016/j.parint.2011.06.002
  8. 8. Willms K, Zurabian R. Taenia crassiceps: in vivo and in vitro models. Parasitology. 2010;137:335-346. DOI: 10.1017/S0031182009991442
  9. 9. Dorais FJ, Esch GW. Growth rate of two Taenia crassiceps strains. Experimental parasitology. 1969;25:395-398. DOI: 10.1016/0014-4894(69)90086-1
  10. 10. Lopez-Briones S, Lamoyi E, Fragoso G, Soloski MJ, Sciutto E. Taenia crassiceps cysticercosis: immune response in susceptible and resistant BALB/c mouse substrains. Parasitology research. 2003;90:236-242. DOI: 10.1007/s00436-003-0848-z
  11. 11. Rodriguez-Sosa M, Satoskar AR, Calderon R, Gomez-Garcia L, Saavedra R, Bojalil R, et al. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infection and immunity. 2002;70:3656-3664. DOI: 10.1128/iai.70.7.3656-3664.2002
  12. 12. Terrazas LI, Bojalil R, Govezensky T, Larralde C. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). The Journal of parasitology. 1998;84:74-81. DOI:
  13. 13. Rodriguez-Sosa M, David JR, Bojalil R, Satoskar AR, Terrazas LI. Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. Journal of immunology. 2002;168:3135-3139. DOI: 10.4049/jimmunol.168.7.3135
  14. 14. Terrazas LI, Cruz M, Rodriguez-Sosa M, Bojalil R, Garcia-Tamayo F, Larralde C. Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitology research. 1999;85:135-141. DOI: 10.1007/s004360050522
  15. 15. Toenjes SA, Spolski RJ, Mooney KA, Kuhn RE. gamma delta T cells do not play a major role in controlling infection in experimental cysticercosis. Parasitology. 1999;119 (Pt 4):413-418. DOI: 10.1017/s0031182099004771
  16. 16. Vaidya A, Singhal S, Dhall S, Manohar A, Mahajan H. Asymptomatic disseminated cysticercosis. Journal of clinical and diagnostic research : JCDR. 2013;7:1761-1763. DOI: 10.7860/JCDR/2013/5465.3269
  17. 17. Herrick JA, Maharathi B, Kim JS, Abundis GG, Garg A, Gonzales I, et al. Inflammation is a key risk factor for persistent seizures in neurocysticercosis. Annals of clinical and translational neurology. 2018;5:630-639. DOI: 10.1002/acn3.562
  18. 18. Naveed M, Zhou QG, Xu C, Taleb A, Meng F, Ahmed B, et al. Gut-brain axis: A matter of concern in neuropsychiatric disorders...! Progress in neuro-psychopharmacology & biological psychiatry. 2021;104:110051. DOI: 10.1016/j.pnpbp.2020.110051
  19. 19. Donskow-Lysoniewska K, Maruszewska-Cheruiyot M, Stear M. The interaction of host and nematode galectins influences the outcome of gastrointestinal nematode infections. Parasitology. 2021;148:648-654. DOI: 10.1017/S003118202100007X
  20. 20. Gieseck RL, 3rd, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nature reviews Immunology. 2018;18:62-76. DOI: 10.1038/nri.2017.90
  21. 21. Walker JA, McKenzie ANJ. TH2 cell development and function. Nature reviews Immunology. 2018;18:121-133. DOI: 10.1038/nri.2017.118
  22. 22. Sun Y, Chauhan A, Sukumaran P, Sharma J, Singh BB, Mishra BB. Inhibition of store-operated calcium entry in microglia by helminth factors: implications for immune suppression in neurocysticercosis. Journal of neuroinflammation. 2014;11:210. DOI: 10.1186/s12974-014-0210-7
  23. 23. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. Journal of immunology. 1989;142:3247-3255. DOI:
  24. 24. Salinas N, Olguin JE, Castellanos C, Saavedra R. T cell suppression in vitro during Toxoplasma gondii infection is the result of IL-2 competition between Tregs and T cells leading to death of proliferating T cells. Scandinavian journal of immunology. 2014;79:1-11. DOI: 10.1111/sji.12120
  25. 25. Pereira WF, Ribeiro-Gomes FL, Guillermo LV, Vellozo NS, Montalvao F, Dosreis GA, et al. Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. Journal of leukocyte biology. 2011;90:1191-1197. DOI: 10.1189/jlb.1110608
  26. 26. Sztein MB, Kierszenbaum F. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes. Immunology. 1992;77:277-283. DOI:
  27. 27. Zepeda N, Solano S, Copitin N, Fernandez AM, Hernandez L, Tato P, et al. Decrease of peritoneal inflammatory CD4(+), CD8(+), CD19(+) lymphocytes and apoptosis of eosinophils in a murine Taenia crassiceps infection. Parasitology research. 2010;107:1129-1135. DOI: 10.1007/s00436-010-1980-1
  28. 28. Spolski RJ, Alexander-Miller MA, Kuhn RE. Suppressed cytotoxic T lymphocyte responses in experimental cysticercosis. Veterinary parasitology. 2002;106:325-330. DOI: 10.1016/s0304-4017(02)00105-x
  29. 29. Adalid-Peralta L, Arce-Sillas A, Fragoso G, Cardenas G, Rosetti M, Casanova-Hernandez D, et al. Cysticerci drive dendritic cells to promote in vitro and in vivo Tregs differentiation. Clinical & developmental immunology. 2013;2013:981468. DOI: 10.1155/2013/981468
  30. 30. Arce-Sillas A, Alvarez-Luquin DD, Cardenas G, Casanova-Hernandez D, Fragoso G, Hernandez M, et al. Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis. Clinical and experimental immunology. 2016;183:271-279. DOI: 10.1111/cei.12709
  31. 31. de Ruiter K, Jochems SP, Tahapary DL, Stam KA, Konig M, van Unen V, et al. Helminth infections drive heterogeneity in human type 2 and regulatory cells. Science translational medicine. 2020;12. DOI: 10.1126/scitranslmed.aaw3703
  32. 32. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nature medicine. 2013;19:739-746. DOI: 10.1038/nm.3179
  33. 33. Olguin JE, Medina-Andrade I, Rodriguez T, Rodriguez-Sosa M, Terrazas LI. Relevance of Regulatory T Cells during Colorectal Cancer Development. Cancers. 2020;12. DOI: 10.3390/cancers12071888
  34. 34. Bueno EC, Vaz AJ, Machado LR, Livramento JA, Avila SL, Ferreira AW. Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis. Clinical and experimental immunology. 2001;126:304-310. DOI: 10.1046/j.1365-2249.2001.01579.x
  35. 35. Tuero I, Palma S, Cabeza F, Saleemi S, Rodriguez S, Gonzales I, et al. A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis. PLoS neglected tropical diseases. 2015;9:e0004143. DOI: 10.1371/journal.pntd.0004143
  36. 36. Coakley G, Harris NL. Interactions between macrophages and helminths. Parasite immunology. 2020;42:e12717. DOI: 10.1111/pim.12717
  37. 37. Brys L, Beschin A, Raes G, Ghassabeh GH, Noel W, Brandt J, et al. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. Journal of immunology. 2005;174:6095-6104. DOI: 10.4049/jimmunol.174.10.6095
  38. 38. Reyes JL, Terrazas CA, Alonso-Trujillo J, van Rooijen N, Satoskar AR, Terrazas LI. Early removal of alternatively activated macrophages leads to Taenia crassiceps cysticercosis clearance in vivo. International journal for parasitology. 2010;40:731-742. DOI: 10.1016/j.ijpara.2009.11.014
  39. 39. Terrazas LI, Montero D, Terrazas CA, Reyes JL, Rodriguez-Sosa M. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. International journal for parasitology. 2005;35:1349-1358. DOI: 10.1016/j.ijpara.2005.06.003
  40. 40. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nature reviews Immunology. 2010;10:170-181. DOI: 10.1038/nri2711
  41. 41. Martinez-Saucedo D, Ruiz-Rosado JD, Terrazas C, Callejas BE, Satoskar AR, Partida-Sanchez S, et al. Taenia crassiceps-Excreted/Secreted Products Induce a Defined MicroRNA Profile that Modulates Inflammatory Properties of Macrophages. Journal of immunology research. 2019;2019:2946713. DOI: 10.1155/2019/2946713
  42. 42. Diaz-Zaragoza M, Jimenez L, Hernandez M, Hernandez-Avila R, Navarro L, Ochoa-Sanchez A, et al. Protein expression profile of Taenia crassiceps cysticerci related to Th1- and Th2-type responses in the mouse cysticercosis model. Acta tropica. 2020;212:105696. DOI: 10.1016/j.actatropica.2020.105696
  43. 43. Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGF-beta Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harbor perspectives in biology. 2016;8. DOI: 10.1101/cshperspect.a021873
  44. 44. Lee GR. The Balance of Th17 versus Treg Cells in Autoimmunity. International journal of molecular sciences. 2018;19. DOI: 10.3390/ijms19030730
  45. 45. Ihara S, Hirata Y, Koike K. TGF-beta in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. Journal of gastroenterology. 2017;52:777-787. DOI: 10.1007/s00535-017-1350-1
  46. 46. Adalid-Peralta L, Rosas G, Arce-Sillas A, Bobes RJ, Cardenas G, Hernandez M, et al. Effect of Transforming Growth Factor-beta upon Taenia solium and Taenia crassiceps Cysticerci. Scientific reports. 2017;7:12345. DOI: 10.1038/s41598-017-12202-z
  47. 47. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860-864. DOI: 10.1126/science.287.5454.860
  48. 48. Wang IC, Fan PC, Lu SC, Fan CK, Su KE. Suppression of host Th1-type granulomatous inflammation by Taenia solium metacestodes is related to down-regulation of osteopontin gene expression. International journal for parasitology. 2008;38:239-248. DOI: 10.1016/j.ijpara.2007.07.010
  49. 49. Wu LC, Zarrin AA. The production and regulation of IgE by the immune system. Nature reviews Immunology. 2014;14:247-259. DOI: 10.1038/nri3632
  50. 50. Garcia G, Sciutto E, Fragoso G, Cruz-Revilla C, Toledo A, Villalobos N, et al. Inhibitory role of antibodies in the development of Taenia solium and Taenia crassiceps toward reproductive and pathogenic stages. The Journal of parasitology. 2001;87:582-586. DOI: 10.1645/0022-3395(2001)087[0582,IROAIT]2.0.CO;2
  51. 51. Bobes RJ, Navarrete-Perea J, Ochoa-Leyva A, Anaya VH, Hernandez M, Cervantes-Torres J, et al. Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen. Infection and immunity. 2017;85. DOI: 10.1128/IAI.00395-17
  52. 52. Nunez G, Villalobos N, Herrera CP, Navarrete-Perea J, Mendez A, Martinez-Maya JJ, et al. Anti-GK1 antibodies damage Taenia crassiceps cysticerci through complement activation. Parasitology research. 2018;117:2543-2553. DOI: 10.1007/s00436-018-5943-2
  53. 53. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clinical immunology. 2006;119:229-240. DOI: 10.1016/j.clim.2006.01.016
  54. 54. Terrazas LI, Bojalil R, Rodriguez-Sosa M, Govezensky T, Larralde C. Taenia crassiceps cysticercosis: a role for prostaglandin E2 in susceptibility. Parasitology research. 1999;85:1025-1031. DOI: 10.1007/s004360050676
  55. 55. Laclette JP, Landa A, Arcos L, Willms K, Davis AE, Shoemaker CB. Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda). Molecular and biochemical parasitology. 1991;44:287-295. DOI: 10.1016/0166-6851(91)90015-x
  56. 56. Laclette JP, Shoemaker CB, Richter D, Arcos L, Pante N, Cohen C, et al. Paramyosin inhibits complement C1. Journal of immunology. 1992;148:124-128. DOI:
  57. 57. Vargas-Parada L, Laclette JP. Gene structure of Taenia solium paramyosin. Parasitology research. 2003;89:375-378. DOI: 10.1007/s00436-002-0761-x
  58. 58. Vibanco-Perez N, Jimenez L, Merchant MT, Landa A. Characterization of glutathione S-transferase of Taenia solium. The Journal of parasitology. 1999;85:448-453. DOI:
  59. 59. Vega-Angeles VT, Terrazas LI, Ledesma-Soto Y, Jimenez L, Landa A. Taenia solium glutathione transferase fraction activates macrophages and favors the development of Th1-type response. Bioscience reports. 2019;39. DOI: 10.1042/BSR20181132
  60. 60. Tato P, Fernandez AM, Solano S, Borgonio V, Garrido E, Sepulveda J, et al. A cysteine protease from Taenia solium metacestodes induce apoptosis in human CD4+ T-cells. Parasitology research. 2004;92:197-204. DOI: 10.1007/s00436-003-1008-1
  61. 61. Sikasunge CS, Phiri IK, Johansen MV, Willingham AL, 3rd, Leifsson PS. Host-cell apoptosis in Taenia solium-induced brain granulomas in naturally infected pigs. Parasitology. 2008;135:1237-1242. DOI: 10.1017/S0031182008004678
  62. 62. Terrazas CA, Gomez-Garcia L, Terrazas LI. Impaired pro-inflammatory cytokine production and increased Th2-biasing ability of dendritic cells exposed to Taenia excreted/secreted antigens: A critical role for carbohydrates but not for STAT6 signaling. International journal for parasitology. 2010;40:1051-1062. DOI: 10.1016/j.ijpara.2010.02.016
  63. 63. Terrazas C, de Dios Ruiz-Rosado J, Amici SA, Jablonski KA, Martinez-Saucedo D, Webb LM, et al. Helminth-induced Ly6C(hi) monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis. Scientific reports. 2017;7:40814. DOI: 10.1038/srep40814
  64. 64. Amit P, Prasad KN, Kumar GR, Shweta T, Sanjeev J, Kumar PV, et al. Immune response to different fractions of Taenia solium cyst fluid antigens in patients with neurocysticercosis. Experimental parasitology. 2011;127:687-692. DOI: 10.1016/j.exppara.2010.11.006
  65. 65. Spolski RJ, Corson J, Thomas PG, Kuhn RE. Parasite-secreted products regulate the host response to larval Taenia crassiceps. Parasite immunology. 2000;22:297-305. DOI: 10.1046/j.1365-3024.2000.00301.x
  66. 66. Logan J, Navarro S, Loukas A, Giacomin P. Helminth-induced regulatory T cells and suppression of allergic responses. Current opinion in immunology. 2018;54:1-6. DOI: 10.1016/j.coi.2018.05.007
  67. 67. Peon AN, Ledesma-Soto Y, Olguin JE, Bautista-Donis M, Sciutto E, Terrazas LI. Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment. Mediators of inflammation. 2017;2017:8494572. DOI: 10.1155/2017/8494572
  68. 68. Reyes JL, Espinoza-Jimenez AF, Gonzalez MI, Verdin L, Terrazas LI. Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis. Cellular immunology. 2011;267:77-87. DOI: 10.1016/j.cellimm.2010.11.006
  69. 69. Callejas BE, Mendoza-Rodriguez MG, Villamar-Cruz O, Reyes-Martinez S, Sanchez-Barrera CA, Rodriguez-Sosa M, et al. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-kappaB and STAT3 regulation. International journal of cancer. 2019;145:3126-3139. DOI: 10.1002/ijc.32626
  70. 70. Leon-Cabrera S, Callejas BE, Ledesma-Soto Y, Coronel J, Perez-Plasencia C, Gutierrez-Cirlos EB, et al. Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis. International journal of biological sciences. 2014;10:948-956. DOI: 10.7150/ijbs.9033
  71. 71. Ledesma-Soto Y, Callejas BE, Terrazas CA, Reyes JL, Espinoza-Jimenez A, Gonzalez MI, et al. Extraintestinal Helminth Infection Limits Pathology and Proinflammatory Cytokine Expression during DSS-Induced Ulcerative Colitis: A Role for Alternatively Activated Macrophages and Prostaglandins. BioMed research international. 2015;2015:563425. DOI: 10.1155/2015/563425
  72. 72. Espinoza-Jimenez A, De Haro R, Terrazas LI. Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages. Mediators of inflammation. 2017;2017:8074329. DOI: 10.1155/2017/8074329

Written By

Jonadab E. Olguín and Luis Ignacio Terrazas

Submitted: 12 May 2021 Reviewed: 26 August 2021 Published: 04 November 2021